- Home
- TTOO vs TPST Comparison
TTOO vs TPST Comparison
Compare TTOO & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTOO
- TPST
- Stock Information
- Founded
- TTOO 2006
- TPST 2011
- Country
- TTOO United States
- TPST United States
- Employees
- TTOO N/A
- TPST N/A
- Industry
- TTOO Medical/Dental Instruments
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- TTOO Health Care
- TPST Health Care
- Exchange
- TTOO Nasdaq
- TPST Nasdaq
- Market Cap
- TTOO 36.4M
- TPST 33.8M
- IPO Year
- TTOO 2014
- TPST N/A
- Fundamental
- Price
- TTOO $1.36
- TPST $1.15
- Analyst Decision
- TTOO Hold
- TPST Strong Buy
- Analyst Count
- TTOO 1
- TPST 4
- Target Price
- TTOO $5.00
- TPST $20.75
- AVG Volume (30 Days)
- TTOO 282.8K
- TPST 6.2M
- Earning Date
- TTOO 11-13-2024
- TPST 11-06-2024
- Dividend Yield
- TTOO N/A
- TPST N/A
- EPS Growth
- TTOO N/A
- TPST N/A
- EPS
- TTOO N/A
- TPST N/A
- Revenue
- TTOO $7,164,000.00
- TPST N/A
- Revenue This Year
- TTOO $50.31
- TPST N/A
- Revenue Next Year
- TTOO $117.92
- TPST N/A
- P/E Ratio
- TTOO N/A
- TPST N/A
- Revenue Growth
- TTOO N/A
- TPST N/A
- 52 Week Low
- TTOO $1.36
- TPST $0.92
- 52 Week High
- TTOO $8.38
- TPST $6.76
- Technical
- Relative Strength Index (RSI)
- TTOO 17.24
- TPST 41.95
- Support Level
- TTOO $1.38
- TPST $0.92
- Resistance Level
- TTOO $1.55
- TPST $1.59
- Average True Range (ATR)
- TTOO 0.12
- TPST 0.17
- MACD
- TTOO 0.02
- TPST -0.02
- Stochastic Oscillator
- TTOO 0.00
- TPST 34.33
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.